Viewing Study NCT02532868


Ignite Creation Date: 2025-12-24 @ 5:46 PM
Ignite Modification Date: 2026-02-02 @ 1:06 AM
Study NCT ID: NCT02532868
Status: TERMINATED
Last Update Posted: 2015-08-26
First Post: 2014-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords: